HK Stock Market Move | NETDRAGON (00777) is currently up more than 4%. NETDRAGON appears at the Volcano Engine AI Innovation Expo. The company has completed the comprehensive cloud migration of its core business systems.
NetDragon (00777) is now up more than 4%, as of the time of writing, up 4.19% at HK$7.95, with a trading volume of HK$13.19 million.
NETDRAGON (00777) is now up more than 4%, as of press time, up 4.19% to HK$7.95, with a turnover of HK$13.1915 million.
On the news front, recently, NETDRAGON's acting CEO Lin Wei attended the Volcano Engine AI Innovation Roadshow and delivered a keynote speech, sharing the new labor ecology of "AI employees". It is reported that in January of this year, NETDRAGON signed an AI ecosystem and joint innovation cooperation framework agreement with Volcano Engine, establishing a long-term cooperation relationship in technology research and development, ecosystem co-construction, commercial applications, and brand synergy in four dimensions. At the end of May, NETDRAGON completed the comprehensive cloudification of its core business systems, being the first to access advanced AI capabilities such as Seedance 2.0 of Volcano Engine, deeply embedding AI capabilities into key processes such as lesson preparation, teaching, practical training, evaluation, and simultaneously accessing Seedance 2.0 API for education AIGC production.
It is worth noting that there have been rumors of Rokid's listing in Hong Kong again recently. In April of this year, Rokid's founder Zhu Mingming responded to listing rumors, stating that the company's restructuring is mainly to optimize the domestic and international business structure, and the team and investors are patient in dealing with future challenges over the next few years, with the primary focus being on new product development. Public information shows that in November 2023, NETDRAGON made a strategic investment of $20 million in Rokid, and the two parties also signed a five-year strategic cooperation agreement.
Related Articles

HK Stock Market Move | CISI FIN(06058) surged nearly 8% with year-on-year net profit after tax increasing by over 50% last year. Its China core asset fund has continued to perform exceptionally well.

A 40% premium! GlaxoSmithKline plc Sponsored ADR (GSK.US) plans to acquire Nuvalent (NUVL.US) for $10.6 billion, stepping up its presence in the cancer drug sector.

Yamato: Increased visibility of AI monetization in Chinese technology stocks, prefer TENCENT (00700) and others.
HK Stock Market Move | CISI FIN(06058) surged nearly 8% with year-on-year net profit after tax increasing by over 50% last year. Its China core asset fund has continued to perform exceptionally well.

A 40% premium! GlaxoSmithKline plc Sponsored ADR (GSK.US) plans to acquire Nuvalent (NUVL.US) for $10.6 billion, stepping up its presence in the cancer drug sector.

Yamato: Increased visibility of AI monetization in Chinese technology stocks, prefer TENCENT (00700) and others.






